Physicians Financial Services, Inc. Gilead Sciences, Inc. Transaction History

Physicians Financial Services, Inc.

$307 Million
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 17, 2022	SELL	$57.72 - $65.01 $609,407 - $686,375	-10,558 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$57.92 - $72.58 $17,376 - $21,774	-300 Reduced 2.76%	10,558 $628,000
Q4 2021 Feb 02, 2022	SELL	$64.88 - $73.64 $90,832 - $103,096	-1,400 Reduced 11.42%	10,858 $788,000
Q3 2021 Oct 27, 2021	SELL	$67.69 - $73.03 $6,769 - $7,303	-100 Reduced 0.81%	12,258 $856,000
Q2 2021 Jul 27, 2021	SELL	$63.47 - $69.35 $58,773 - $64,218	-926 Reduced 6.97%	12,358 $851,000
Q1 2021 May 21, 2021	BUY	$60.0 - $68.46 $20,040 - $22,865	334 Added 2.58%	13,284 $859,000
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $49,568 - $56,481	-875 Reduced 6.33%	12,950 $754,000
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $8,197 - $10,306	132 Added 0.96%	13,825 $874,000
Q2 2020 Jul 28, 2020	BUY	$72.34 - $84.0 $33,782 - $39,228	467 Added 3.53%	13,693 $1.05 Million
Q1 2020 Apr 27, 2020	SELL	$62.63 - $80.22 $18,789 - $24,066	-300 Reduced 2.22%	13,226 $989,000
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $76,100 - $83,708	-1,235 Reduced 8.37%	13,526 $879,000
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $53,133 - $58,650	-850 Reduced 5.44%	14,761 $936,000
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $3,093 - $3,469	50 Added 0.32%	15,611 $1.06 Million
Q1 2019 Apr 12, 2019	BUY	$62.53 - $70.05 $38,143 - $42,730	610 Added 4.08%	15,561 $1.01 Million
Q4 2018 Jan 22, 2019	SELL	$60.54 - $79.0 $41,348 - $53,957	-683 Reduced 4.37%	14,951 $935,000
Q2 2018 Aug 21, 2018	SELL	$64.88 - $75.68 $3,957 - $4,616	-61 Reduced 0.39%	15,634 $1.11 Million
Q1 2018 Apr 17, 2018	BUY	$72.84 - $88.8 $69,198 - $84,360	950 Added 6.44%	15,695 $1.17 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $86,803 - $101,894	-1,220 Reduced 7.64%	14,745 $1.06 Million
Q3 2017 Nov 01, 2017	BUY	$72.11 - $85.47 $1.15 Million - $1.36 Million	15,965	15,965 $1.29 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Physicians Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Physicians Financial Services, Inc. with notifications on news.

Account